Original-Research: INDUS Holding AG - from NuWays AG
Classification of NuWays AG to INDUS Holding AG
Case fully intact despite PW; chg. est. Topic: On Thursday, INDUS released its preliminary Q3 sales and EBIT figures in line with our estimates. Further, due to non-cash goodwill impairments, the company revised its FY24e EBIT guidance. Impairment of goodwill and intangible assets: Due to the annual assessment, INDUS had to reduce the book value of goodwill and other intangible assets in the amount of € 5.2m in the Infrastructure segment and € 1.5m in the Materials segment. The need for these impairments resulted from reduced forecasts of future cash flow for the two units. Preliminary Q3 sales came in at c. € 441m (eNuW: € 445m), a slight decrease of c. 4% yoy due to a challenging macroeconomic environment. Reported EBIT remained roughly unchanged yoy at a solid € 31.8m (eNuW: € 30.8m). However, adjusting for impairments of € 6.7m in Q3’24 and € 17.6m in Q3’23 due to higher interest rates, EBIT decreased by 22.4% yoy. FY EBIT guidance revised: While INDUS confirmed its FY24e top-line and FCF guidance of € 1.70-1.80bn and € 110m, they reduced their EBIT forecast to € 115-125m (previously: € 125-145m) due to impairments. However, the guidance looks plausible in our view as INDUS has achieved by now c. 75% of the lower end of the sales guidance in the first three quarters while the situation has improved already compared to H1’24 in terms of sales. Moreover, the revised EBIT outlook implies an EBIT margin of 5.1% in Q4’24e at mid-point, which looks conservative to us after 7.5% in 9M’24. All things considered, this is rather positive news. Preliminary results are in line with our estimates, despite the € 6.7m impairment. Even though INDUS decreased its FY EBIT outlook due to impairments, it is a non-cash expenses and hence it will not affect FCF. Further, the company reiterated its FCF guidance of € 110m (eNuW: € 114m), which implies a strong FCFY24e of c. 10%. Therefore, we reiterate our BUY rating with an unchanged PT of € 34 based on FCFY24e and confirm the stock as one of NuWays’ Alpha Picks. You can download the research here: http://www.more-ir.de/d/31169.pdf For additional information visit our website: www.nuways-ag.com/research Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
2021313 04.11.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.